Quick Answer
UTAH MEDICAL PRODUCTS INC reported Operating Income Loss of $11.40 million for the year ending 2025.
- UTAH MEDICAL PRODUCTS INC showed a decrease of -16.1% in Operating Income Loss from 2024 to 2025.
- This data is from UTAH MEDICAL PRODUCTS INC's annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), UTAH MEDICAL PRODUCTS INC's Operating Income Loss has grown by 20.9%.
- Historical annual values: Fiscal year 2025: $11.40 million | Fiscal year 2024: $13.59 million | Fiscal year 2023: $16.78 million | Fiscal year 2022: $19.79 million | Fiscal year 2021: $18.88 million | Fiscal year 2020: $13.71 million | Fiscal year 2019: $17.63 million | Fiscal year 2018: $18.70 million | Fiscal year 2017: $19.01 million | Fiscal year 2016: $16.19 million | Fiscal year 2015: $15.65 million | Fiscal year 2014: $16.20 million | Fiscal year 2013: $14.83 million | Fiscal year 2012: $15.20 million | Fiscal year 2011: $11.84 million | Fiscal year 2010: $8.92 million | Fiscal year 2009: $9.43 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: